Solaxa Announces Phase 3 Clinical Trial for Spinocerebellar Ataxia Type 27B
Press Release • Mar 28, 2025 12:00 EDT BETHESDA, Md., March 28, 2025 (Ecnetnews.com) - Solaxa Inc., a biopharmaceutical public ...
Press Release • Mar 28, 2025 12:00 EDT BETHESDA, Md., March 28, 2025 (Ecnetnews.com) - Solaxa Inc., a biopharmaceutical public ...
NEWARK, CA, March 8, 2025 (Ecnetnews.com) - Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced new icotrokinra (JNJ-2113) data ...
NEW YORK, January 3, 2025 (Ecnetnews.com) - The healthcare IT market is evolving, with specialty-focused EHR vendors emerging as leaders ...
WARSAW, Poland, September 27, 2024 (Ecnetnews.com) - Humaneva Inc. has entered into a significant investment agreement with Viking Global Investors, ...
ECNETNews.com proudly acknowledges support from UNESCO’s International Programme for the Development of Communications, bolstering our mission to deliver accurate, unbiased news and foster informed communities across the World
ECNETNews.com is a historic important News Website running now over 20 years, since 2004 serving as neutral news source.
© 2024 ECNETNEWS - International News site for open minded news ECNETNews.com.